| Date Filed | Type | Description |
| 08/17/2023 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 72,931 shares
@ $52.4, valued at
$3.8M
|
|
| 08/17/2023 |
3/A
| Bitterman Kevin (Director) has filed a Form 3/A on Disc Medicine, Inc. |
| 06/09/2023 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Granted 7,136 options to buy
@ $45.69, valued at
$326k
|
|
| 01/03/2023 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Granted 7,000 options to buy
@ $13.5, valued at
$94.5k
|
|
| 01/03/2023 |
3
| Bitterman Kevin (Director) has filed a Form 3 on Disc Medicine, Inc. |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $25.2, valued at
$327.6k
|
|
| 11/12/2019 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $19.97, valued at
$519.2k
|
|
| 06/25/2019 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Converted 3,469,759 shares
@ $0
Converted 235,099 shares
@ $0
Bought 270,000 shares
@ $16, valued at
$4.3M
Converted 10,666,667 preferred shares
@ $0
Converted 722,737 preferred shares
@ $0 |
|
| 06/19/2019 |
3
| Bitterman Kevin (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2016 |
4
| Bitterman Kevin (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 15,000 options to buy
@ $4.64, valued at
$69.6k
|
|